Deferred Tax Assets, Net of Valuation Allowance
Abbott Deferred Tax Assets, Net of Valuation Allowance decreased by 5.5% to $9.83B in Q4 2025 compared to the prior quarter. Year-over-year, this metric declined by 5.5%, from $10.41B to $9.83B. Over 4 years (FY 2021 to FY 2025), Deferred Tax Assets, Net of Valuation Allowance shows an upward trend with a 37.2% CAGR. This decline may warrant attention — for this metric, higher values are generally preferred.
Analysis
How to read this metric
An increase indicates a stronger outlook for tax savings and future profitability, while a decrease suggests lower expected tax benefits.
Detailed definition
This represents the net value of deferred tax assets after subtracting the valuation allowance. It is the amount of tax...
Peer comparison
Standard metric for assessing the net tax position of a company relative to its peers.
other_deferred_tax_assets_netHistorical Data
| Q4 '21 | Q4 '22 | Q4 '23 | Q4 '24 | Q4 '25 | |
|---|---|---|---|---|---|
| Value | $2.77B | $2.72B | $2.86B | $10.41B | $9.83B |
| QoQ Change | — | -1.9% | +5.3% | +263.6% | -5.5% |
| YoY Change | — | -1.9% | +5.3% | +263.6% | -5.5% |
Deferred Tax Assets, Net of Valuation Allowance at Other Companies
Frequently Asked Questions
- What is Abbott's deferred tax assets, net of valuation allowance?
- Abbott (ABT) reported deferred tax assets, net of valuation allowance of $9.83B in Q4 2025.
- How has Abbott's deferred tax assets, net of valuation allowance changed year-over-year?
- Abbott's deferred tax assets, net of valuation allowance decreased by 5.5% year-over-year, from $10.41B to $9.83B.
- What is the long-term trend for Abbott's deferred tax assets, net of valuation allowance?
- Over 4 years (2021 to 2025), Abbott's deferred tax assets, net of valuation allowance has grown at a 37.2% compound annual growth rate (CAGR), from $2.77B to $9.83B.
- What does deferred tax assets, net of valuation allowance mean?
- The actual value of tax-saving assets that the company expects to be able to use.